Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jul;45(8):1432-1441.
doi: 10.1007/s00259-018-3984-5. Epub 2018 Mar 9.

Parametric mapping using spectral analysis for 11C-PBR28 PET reveals neuroinflammation in mild cognitive impairment subjects

Affiliations

Parametric mapping using spectral analysis for 11C-PBR28 PET reveals neuroinflammation in mild cognitive impairment subjects

Zhen Fan et al. Eur J Nucl Med Mol Imaging. 2018 Jul.

Abstract

Purpose: Neuroinflammation and microglial activation play an important role in amnestic mild cognitive impairment (MCI) and Alzheimer's disease. In this study, we investigated the spatial distribution of neuroinflammation in MCI subjects, using spectral analysis (SA) to generate parametric maps and quantify 11C-PBR28 PET, and compared these with compartmental and other kinetic models of quantification.

Methods: Thirteen MCI and nine healthy controls were enrolled in this study. Subjects underwent 11C-PBR28 PET scans with arterial cannulation. Spectral analysis with an arterial plasma input function was used to generate 11C-PBR28 parametric maps. These maps were then compared with regional 11C-PBR28 VT (volume of distribution) using a two-tissue compartment model and Logan graphic analysis. Amyloid load was also assessed with 18F-Flutemetamol PET.

Results: With SA, three component peaks were identified in addition to blood volume. The 11C-PBR28 impulse response function (IRF) at 90 min produced the lowest coefficient of variation. Single-subject analysis using this IRF demonstrated microglial activation in five out of seven amyloid-positive MCI subjects. IRF parametric maps of 11C-PBR28 uptake revealed a group-wise significant increase in neuroinflammation in amyloid-positive MCI subjects versus HC in multiple cortical association areas, and particularly in the temporal lobe. Interestingly, compartmental analysis detected group-wise increase in 11C-PBR28 binding in the thalamus of amyloid-positive MCI subjects, while Logan parametric maps did not perform well.

Conclusions: This study demonstrates for the first time that spectral analysis can be used to generate parametric maps of 11C-PBR28 uptake, and is able to detect microglial activation in amyloid-positive MCI subjects. IRF parametric maps of 11C-PBR28 uptake allow voxel-wise single-subject analysis and could be used to evaluate microglial activation in individual subjects.

Keywords: 11C–PBR28; Compartmental modelling; Logan graphic analysis; MCI; PET; Spectral analysis.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

Dr. Edison was funded by the Medical Research Council and now by Higher Education Funding Council for England (HEFCE). He has also received grants from Alzheimer’s Research UK, Alzheimer’s Drug Discovery Foundation, Alzheimer’s Society, UK, Novo Nordisk, and GE Healthcare. He is also a consultant to Pfizer. Prof. Brooks has received research grants and non-financial support from the Medical Research Council, grants from Alzheimer’s Research Trust, during the conduct of the study; other from GE Healthcare, personal fees from AstraZeneca, personal fees from Cytox, personal fees from Shire, personal fees from Novartis, personal fees from GSK, Holland, personal fees from Navidea, personal fees from UCB, personal fees from Acadia, grants from Michael J Fox Foundation, grants from European Commission, outside the submitted work. Mattia Veronese is supported by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and by King’s College London.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Figures

Fig. 1
Fig. 1
a Kinetic spectrum for a healthy control subject, which revealed three different components [at position βi of 7.07e-04 s-1 (blue), 1.58e-03 s-1 (green) and 5.01e-03 s-1 (red) with amplitude αi of 8.35e-04 s-1, 1.03e-03 s-1, and 1.21e-03 s-1] with fractional blood volume (bv) of 0.065 (cyan). b Predicted curves using spectral analysis IRF (impulse response function) for tracer activity (dashed line) which was measured by the sum of three individual components of the spectrum. The blue (KI), green and red curves corresponded to the three component peaks in the spectrum
Fig. 2
Fig. 2
Individual IRF-90 and Logan VT parametric maps demonstrated with corresponding MR image. Upper panel displays an MCI patient, middle panel shows a healthy control (HC), and lower panel demonstrates the group-wise average image (Mean) and standard deviation image (SD). The colour bar on the left represents the colour scale used for IRF-90 images, and the colour bar on the right represents the colour scale used for Logan VT images
Fig. 3
Fig. 3
Single-subject VOI analysis of IRF. The colour map represents the significant clusters of increased 11C–PBR28 binding for each MCI patient compared to healthy control cohort. Aβ + and Aβ- represent amyloid-positive MCI and amyloid-negative MCI subjects respectively. The colour bar indicates the significant Z-score which was used for the colour-coded map
Fig. 4
Fig. 4
11C–PBR28 blood data. a Parent fraction in arterial plasma. b Plasma over blood ratio
Fig. 5
Fig. 5
a The correlation between 11C–PBR28 IRF-90 and Logan VT in frontal lobe and temporal lobe. b The correlation between 11C–PBR28 IRF and 2TCM4k-1 K VT in frontal lobe and temporal lobe. c The correlation between 11C–PBR28 IRF and 2TCM4k VT in frontal lobe and temporal lobe. d The correlation between 2TCM4k-1 K VT and 2TCM4k VT in frontal lobe and temporal lobe

Similar articles

Cited by

References

    1. Calsolaro V, Edison P. Neuroinflammation in Alzheimer’s disease: current evidence and future directions. Alzheimers Dement. 2016;12(6):719–732. doi: 10.1016/j.jalz.2016.02.010. - DOI - PubMed
    1. Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, et al. Neuroinflammation in Alzheimer’s disease. Lancet Neurol. 2015;14(4):388–405. doi: 10.1016/S1474-4422(15)70016-5. - DOI - PMC - PubMed
    1. Higuchi M, Ji B, Maeda J, Sahara N, Suhara T. In vivo imaging of neuroinflammation in Alzheimer’s disease. Clin Exp Neuroimmunol. 2016;7(2):139–144. doi: 10.1111/cen3.12308. - DOI
    1. Edison P, Ahmed I, Fan Z, Hinz R, Gelosa G, Ray Chaudhuri K, et al. Microglia, amyloid, and glucose metabolism in Parkinson’s disease with and without dementia. Neuropsychopharmacology. 2013;38(6):938–949. doi: 10.1038/npp.2012.255. - DOI - PMC - PubMed
    1. Kreisl WC, Lyoo CH, Liow JS, Wei M, Snow J, Page E, et al. (11)C-PBR28 binding to translocator protein increases with progression of Alzheimer’s disease. Neurobiol Aging. 2016;44:53–61. doi: 10.1016/j.neurobiolaging.2016.04.011. - DOI - PMC - PubMed